Distribution of endothelin receptor subtypes ETA and ETB in the rat kidney - PubMed (original) (raw)
. 2006 Nov;54(11):1193-203.
doi: 10.1369/jhc.5A6888.2006. Epub 2006 Jul 11.
Affiliations
- PMID: 16835394
- DOI: 10.1369/jhc.5A6888.2006
Distribution of endothelin receptor subtypes ETA and ETB in the rat kidney
Martina Wendel et al. J Histochem Cytochem. 2006 Nov.
Abstract
The endothelin (ET) receptor system is markedly involved in the regulation of renal function under both physiological and pathophysiological conditions. The present study determined the detailed cellular localization of both ET receptor subtypes, ET(A) and ET(B), in the vascular and tubular system of the rat kidney by immunofluorescence microscopy. In the vascular system we observed both ET(A) and ET(B) receptors in the media of interlobular arteries and afferent and efferent arterioles. In interlobar and arcuate arteries, only ET(A) receptors were present on vascular smooth muscle cells. ET(B) receptor immunoreactivity was sparse on endothelial cells of renal arteries, whereas there was strong labeling of peritubular and glomerular capillaries as well as vasa recta endothelium. ET(A) receptors were evident on glomerular mesangial cells and pericytes of descending vasa recta bundles. In the renal tubular system, ET(B) receptors were located in epithelial cells of proximal tubules and inner medullary collecting ducts, whereas ET(A) receptors were found in distal tubules and cortical collecting ducts. Distribution of ET(A) and ET(B) receptors in the vascular and tubular system of the rat kidney reported in the present study supports the concept that both ET receptor subtypes cooperate in mediating renal cortical vasoconstriction but exert differential and partially antagonistic effects on renal medullary function.
Similar articles
- Endothelin receptor-mediated vasodilatation: effects of organ culture.
Nilsson D, Wackenfors A, Gustafsson L, Ugander M, Paulsson P, Ingemansson R, Edvinsson L, Malmsjö M. Nilsson D, et al. Eur J Pharmacol. 2008 Jan 28;579(1-3):233-40. doi: 10.1016/j.ejphar.2007.09.031. Epub 2007 Oct 3. Eur J Pharmacol. 2008. PMID: 17964568 - Urinary excretion of endothelin receptors ET A and ET B in hypertensive patients and normotensive subjects.
Karram T, Khamaisi M, Bishara B, Ramadan R, Nitecki S, Ben-Izhak O, Meretyk S, Winaver J, Heyman SN, Hoffman A, Abassi Z. Karram T, et al. Kidney Blood Press Res. 2009;32(4):293-303. doi: 10.1159/000243053. Epub 2009 Oct 1. Kidney Blood Press Res. 2009. PMID: 19797914 - Increased ET-1 and reduced ET(B) receptor expression in uremic hypertensive rats.
D'Amours M, Chbinou N, Beaudoin J, Lebel M, Larivière R. D'Amours M, et al. Clin Exp Hypertens. 2010 Jan;32(1):61-9. doi: 10.3109/10641960902993095. Clin Exp Hypertens. 2010. PMID: 20144075 - Expression and function of ETA and ETB receptors in SSc.
Frommer KW, Müller-Ladner U. Frommer KW, et al. Rheumatology (Oxford). 2008 Oct;47 Suppl 5:v27-8. doi: 10.1093/rheumatology/ken274. Rheumatology (Oxford). 2008. PMID: 18784135 Review. - Endothelin and endothelin receptors in the renal and cardiovascular systems.
Vignon-Zellweger N, Heiden S, Miyauchi T, Emoto N. Vignon-Zellweger N, et al. Life Sci. 2012 Oct 15;91(13-14):490-500. doi: 10.1016/j.lfs.2012.03.026. Epub 2012 Mar 28. Life Sci. 2012. PMID: 22480517 Review.
Cited by
- Endothelin Inhibitors in Chronic Kidney Disease: New Treatment Prospects.
Rakotoarison A, Kepinska M, Konieczny A, Władyczak K, Janczak D, Hałoń A, Donizy P, Banasik M. Rakotoarison A, et al. J Clin Med. 2024 Oct 11;13(20):6056. doi: 10.3390/jcm13206056. J Clin Med. 2024. PMID: 39458006 Free PMC article. Review. - Mechanism of protective actions of sparsentan in the kidney: lessons from studies in models of chronic kidney disease.
Kohan DE, Bedard PW, Jenkinson C, Hendry B, Komers R. Kohan DE, et al. Clin Sci (Lond). 2024 Jun 5;138(11):645-662. doi: 10.1042/CS20240249. Clin Sci (Lond). 2024. PMID: 38808486 Free PMC article. Review. - Quantifying the integrated physiological effects of endothelin-1 on cardiovascular and renal function in healthy subjects: a mathematical modeling analysis.
Yu H, Greasley P, Lambers-Heerspink H, Boulton DW, Hamrén B, Hallow KM. Yu H, et al. Front Pharmacol. 2024 Apr 5;15:1332394. doi: 10.3389/fphar.2024.1332394. eCollection 2024. Front Pharmacol. 2024. PMID: 38645552 Free PMC article. - Spice Up Your Kidney: A Review on the Effects of Capsaicin in Renal Physiology and Disease.
Musolino M, D'Agostino M, Zicarelli M, Andreucci M, Coppolino G, Bolignano D. Musolino M, et al. Int J Mol Sci. 2024 Jan 8;25(2):791. doi: 10.3390/ijms25020791. Int J Mol Sci. 2024. PMID: 38255865 Free PMC article. Review. - Targeting the Endothelin A Receptor in IgA Nephropathy.
Kohan DE, Barratt J, Heerspink HJL, Campbell KN, Camargo M, Ogbaa I, Haile-Meskale R, Rizk DV, King A. Kohan DE, et al. Kidney Int Rep. 2023 Aug 4;8(11):2198-2210. doi: 10.1016/j.ekir.2023.07.023. eCollection 2023 Nov. Kidney Int Rep. 2023. PMID: 38025243 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources